Clark Capital Management Group’s Quest Diagnostics DGX Stock Holding History

Clark Capital Management Group’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$51.3M	Buy	241,846 +6,424	+3%	+$1.26M	0.28%	115
2026 Q1	$46.1M	Buy	+235,422	New	+$45.7M	0.28%	113
2023 Q4	–	Sell	-5,960	Closed	-$726K	–	376
2023 Q3	$726K	Buy	5,960 +9	+0.2%	+$1.2K	0.01%	270
2023 Q2	$836K	Buy	5,951 +1,526	+34%	+$210K	0.01%	263
2023 Q1	$626K	Buy	+4,425	New	+$633K	0.01%	273
2017 Q4	–	Sell	-301,785	Closed	-$28.3M	–	282
2017 Q3	$28.3M	Sell	301,785 -54,900	-15%	-$5.83M	0.95%	25
2017 Q2	$39.6M	Buy	356,685 +112,985	+46%	+$11.9M	1.54%	7
2017 Q1	$23.9M	Buy	+243,700	New	+$23.2M	1.06%	25
2015 Q3	–	Sell	-2,848	Closed	-$207K	–	312
2015 Q2	$207K	Sell	2,848 -95,455	-97%	-$7.05M	0.02%	311
2015 Q1	$7.55M	Buy	+98,303	New	+$7.04M	0.69%	50

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Clark Capital Management Group's DGX Position: Q2 2026 in Review

Clark Capital Management Group increased its Quest Diagnostics (DGX) stake by 2.7% in Q2 2026, buying an estimated $1.26M and bringing the position to 241,846 shares worth $51.3M. The position accounts for 0.28% of the portfolio, ranked #115.

Clark Capital Management Group first reported a position in DGX in Q1 2015 and has held it in 10 quarters since. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Clark Capital Management Group held 241,846 shares of Quest Diagnostics worth $51.3M as of Q2 2026.
Clark Capital Management Group bought 6,424 Quest Diagnostics shares in Q2 2026, an estimated $1.26M.
Quest Diagnostics made up 0.28% of Clark Capital Management Group's portfolio in Q2 2026, its #115 holding.
Clark Capital Management Group first reported a position in Quest Diagnostics in Q1 2015 and has held it in 10 quarters since.
1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Clark Capital Management Group's 13F filing for Q2 2026, filed 11 Aug 2026.